Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Invested Capital (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Invested Capital for 16 consecutive years, with $24.5 million as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 12.2% to $24.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.5 million through Dec 2025, down 12.2% year-over-year, with the annual reading at $24.5 million for FY2025, 12.2% down from the prior year.
  • Invested Capital hit $24.5 million in Q4 2025 for Cumberland Pharmaceuticals, down from $26.1 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $47.8 million in Q2 2021 to a low of $24.5 million in Q4 2025.
  • Historically, Invested Capital has averaged $34.7 million across 5 years, with a median of $35.8 million in 2022.
  • Biggest five-year swings in Invested Capital: decreased 29.33% in 2024 and later increased 6.33% in 2025.
  • Year by year, Invested Capital stood at $42.6 million in 2021, then fell by 15.56% to $36.0 million in 2022, then decreased by 18.66% to $29.3 million in 2023, then dropped by 4.46% to $28.0 million in 2024, then decreased by 12.2% to $24.5 million in 2025.
  • Business Quant data shows Invested Capital for CPIX at $24.5 million in Q4 2025, $26.1 million in Q3 2025, and $27.7 million in Q2 2025.